BMS Archive

Plant · Scientific monograph

Allium sativum

Garlic

For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.

Research areas: Cardiovascular System, Microbial Research, Blood Pressure Mechanisms, Glucose & Metabolic Research

Research overview

Historical use

Garlic is among the most ancient of all medicinal plants, with documented use spanning over 5,000 years across virtually every major civilisation. Mentioned in the Ebers Papyrus (c. 1550 BCE) for treating heart disease, tumours, and worms. Egyptian pyramid builders were fed garlic to maintain strength. Hippocrates prescribed it for respiratory conditions, GI disorders, and fatigue. Roman soldiers ate it for endurance. Louis Pasteur confirmed its antibacterial properties in 1858. During WWI and WWII it was used as an antiseptic for wounds when conventional antibiotics were unavailable.

Modern research context

A 2016 meta-analysis of 17 RCTs (n=881) found garlic preparations significantly reduced systolic BP by 8.7 mmHg and diastolic BP by 6.1 mmHg in hypertensive patients, comparable to first-line antihypertensives at standard doses [1]. A 2015 systematic review and meta-analysis of 39 primary studies demonstrated significant reductions in total cholesterol and LDL-C with garlic supplementation [2]. Aged garlic extract (AGE) is the most studied form for cardiovascular outcomes; a 2014 RCT showed AGE significantly reduced coronary artery calcium progression versus placebo [6]. Antimicrobial activity of allicin against MRSA, H. pylori, Candida, and multi-drug-resistant Enterococcus is well-documented in vitro and in limited clinical settings [3]. Allicin instability (t½ <1 hour in blood) means bioavailability depends critically on preparation method; only enteric-coated or aged garlic formulations provide reliable plasma concentrations of stable organosulfur metabolites [4]. Epidemiological data suggest inverse association with colorectal cancer risk [5].

Adverse effects

Halitosis (garlic breath) and body odour — the most common and socially limiting effects. GI irritation (heartburn, nausea, flatulence), particularly from raw garlic. Antiplatelet effects — increased bleeding time. Contact dermatitis (topical). Rare: anaphylaxis (IgE-mediated allergy). Garlic allergy is distinct from Allium/leek allergy. Diallyl disulfide can cause haemolytic anaemia in cats and dogs (not humans at dietary doses).

Contraindications

Anticoagulant or antiplatelet therapy — additive bleeding risk; clinical monitoring required. Discontinue high-dose supplements ≥1 week before surgery. HIV medications (saquinavir, ritonavir) — garlic extract significantly reduces saquinavir plasma levels (CYP3A4 and P-gp induction). Thyroid medications — garlic at high doses may affect thyroid hormone metabolism. Caution in pemphigus (inflammatory skin condition — case reports of exacerbation).

Clinical and phytochemical data

Used part

Bulb (clove; fresh, dried powder, aged garlic extract, or garlic oil)

Primary active compounds

  • Allicin (allyl 2-propenethiosulfinate — formed from alliin by alliinase on crushing; primary antimicrobial compound; unstable)

  • S-Allylcysteine (SAC — stable; primary active in aged garlic extract; cardioprotective)

  • S-Allylmercaptocysteine (SAMC)

  • Diallyl disulfide (DADS) and diallyl trisulfide (DATS — primary anticancer thiosulfinates)

  • Ajoene (antiplatelet, antifungal; formed from allicin in oil)

  • Alliin (stable precursor; inactive until enzymatic conversion by alliinase)

  • Fructooligosaccharides (prebiotic; gut microbiome-modulating)

Mechanism of action

Allicin and organosulfur compounds (DADS, DATS) inhibit HMG-CoA reductase, reducing hepatic cholesterol synthesis. Antihypertensive via enzymatic production of hydrogen sulfide (H₂S) from allicin metabolites — H₂S activates vascular KATP channels, hyperpolarising vascular smooth muscle, causing vasodilation. Also inhibits ACE (angiotensin-converting enzyme), reducing angiotensin II–mediated vasoconstriction. Antiplatelet via inhibition of TXA2 synthesis and COX-1-dependent arachidonate metabolism, and direct inhibition of fibrinogen binding to GPIIb/IIIa receptor. SAC upregulates Nrf2/HO-1 antioxidant pathway. DATS induces tumour cell apoptosis via reactive sulfur species generating mitochondrial oxidative stress in cancer cells. Antimicrobial: allicin covalently modifies cysteine proteases and thiol-containing enzymes in pathogens.

Pharmacokinetics

Absorption

Allicin itself is chemically unstable and is not detected in human plasma after garlic ingestion — it decomposes rapidly in gastric acid and the intestinal environment to produce secondary allyl sulfide compounds. Human studies using GC-MS and HPLC-MS have detected garlic-derived volatile metabolites (including allyl methyl sulfide, the primary breath metabolite) and the stable compound S-allylcysteine (SAC) in human plasma and urine following ingestion of both dehydrated garlic and aged garlic extract preparations [1]. SAC, the primary active compound in aged garlic, is substantially more bioavailable than allicin-releasing preparations.

Distribution

No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — The allyl sulfide metabolites derived from allicin (allyl methyl sulfide, diallyl disulfide) are volatile and lipophilic, distributing broadly into tissues and detected in exhaled breath — explaining the characteristic garlic odour after ingestion. SAC is less volatile and distributes more selectively. No formal volume-of-distribution measurements exist for SAC or allicin-derived metabolites in humans.

Metabolism

The metabolic fate of garlic compounds in humans is complex and compound-dependent. Allicin spontaneously degrades to diallyl sulfide, diallyl disulfide, diallyl trisulfide, and ajoene without requiring enzymatic catalysis. These are subsequently metabolised via glutathione conjugation and S-adenosylmethionine-dependent pathways to produce allyl methyl sulfide — the persistent exhaled volatile detected hours after garlic consumption [1]. SAC undergoes N-acetylation to form N-acetyl-S-allylcysteine (NASC) as its primary Phase II metabolite.

Excretion

S-allylcysteine was directly quantified in human plasma and urine by HPLC-MS following garlic extract ingestion [1], confirming renal excretion as a significant elimination route for this stable water-soluble metabolite. Volatile allyl sulfides are substantially eliminated via pulmonary exhalation — a distinctive feature of garlic pharmacokinetics. The persistent garlic breath odour lasting 12–24 h reflects the slow pulmonary clearance of allyl methyl sulfide.

Safety and interactions

Drug interactions

Warfarin and anticoagulants — additive antiplatelet effects (TXA2 inhibition); INR elevation documented in case reports; monitor closely. Antiplatelet drugs (aspirin, clopidogrel) — additive bleeding risk. Saquinavir (HIV protease inhibitor) — garlic extract reduces saquinavir AUC by up to 51% via CYP3A4 and P-gp induction; contraindicated with ritonavir-boosted regimens. Other HIV antiretrovirals — potential CYP3A4 induction; monitor drug levels. Isoniazid (TB treatment) — reduced absorption when taken together. Insulin and antidiabetic drugs — modest additive glucose-lowering effect.

Toxicity

LD50 >30 mL/kg (garlic oil) in rodents. No significant human toxicity at dietary or supplemental doses. Topical allicin can cause chemical burns and blistering on skin (reports of self-treatment with raw garlic). GI haemorrhage risk at very high doses in combination with anticoagulants. Diallyl sulfide is a CYP2E1 substrate and may modestly modify acetaminophen hepatotoxicity at high doses.

Special precautions

Pregnancy

Culinary use is universally considered safe in pregnancy. High-dose supplements (>900 mg garlic extract/day) not formally studied; avoid as a precaution given antiplatelet activity.

Lactation

Garlic compounds transfer to breast milk, altering flavour and potentially affecting infant feeding behaviour — variable responses have been reported. Culinary quantities have an extensive history of use during breastfeeding without documented harm; formal clinical safety data during lactation are limited.

Hepatic impairment

Hepatoprotective at standard doses. CYP3A4 induction by high-dose garlic may alter metabolism of co-administered hepatically cleared drugs. No direct hepatotoxicity documented.

Renal impairment

No specific contraindication. Thiol metabolites renally excreted; accumulation possible in severe CKD. No dose adjustment guidelines established.

Sources and references

  1. [1] - Ried K., "Garlic Lowers Blood Pressure in Hypertensive Individuals, Regulates Serum Cholesterol, and Stimulates Immunity: An Updated Meta-analysis and Review.", J Nutr, 2016, PMID: 27284200
  2. [2] - Rohner A, Ried K, Sobenin IA, Bucher HC, Nordmann AJ., "A systematic review and metaanalysis on the effects of garlic preparations on blood pressure in individuals with hypertension.", Am J Hypertens, 2015, PMID: 25548110
  3. [3] - Bayan L, Koulivand PH, Gorji A., "Garlic: a review of potential therapeutic effects.", Avicenna J Phytomed, 2014, PMID: 25050296
  4. [4] - Borlinghaus J, Albrecht F, Gruhlke MC, Nwachukwu ID, Slusarenko AJ., "Allicin: chemistry and biological properties.", Molecules, 2014, PMID: 25006664
  5. [5] - Shukla Y, Kalra N., "Cancer chemoprevention with garlic and its constituents.", Cancer Lett, 2007, PMID: 16945472
  6. [6] - Budoff MJ, Ahmadi N, Gul KM et al., "Aged garlic extract supplemented with B vitamins, folic acid and L-arginine retards the progression of subclinical atherosclerosis: a randomized clinical trial.", Prev Med, 2009, PMID: 19682504

Additional source links

Continue browsing